Skip to Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

14 November 2019

32 Pages

Lung Microbiome in Asthma: Current Perspectives

,
,
,
,
,
,
,
and
1
ICU, 1st Department of Pulmonary Medicine, “Sotiria” Hospital; Athens School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
2
Koropi Academic Health Care Center, Koropi, 19400 Attica, Greece
3
4th Department of Internal Medicine, Attikon University Hospital, 12462 Athens, Greece
4
Dipartimento di Fisiopatologia e dei Trapianti, Università degli Studi di Milano, 20122 Milan, Italy

Abstract

A growing body of evidence implicates the human microbiome as a potentially influential player actively engaged in shaping the pathogenetic processes underlying the endotypes and phenotypes of chronic respiratory diseases, particularly of the airways. In this article, we specifically review current evidence on the characteristics of lung microbiome, and specifically the bacteriome, the modes of interaction between lung microbiota and host immune system, the role of the “lung–gut axis”, and the functional effects thereof on asthma pathogenesis. We also attempt to explore the possibilities of therapeutic manipulation of the microbiome, aiming at the establishment of asthma prevention strategies and the optimization of asthma treatment.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.